chrX-1309488-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_172246.4(CSF2RA):c.1033G>A(p.Gly345Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0151 in 1,613,916 control chromosomes in the GnomAD database, including 3,001 homozygotes. There are 10,907 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_172246.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0783 AC: 11919AN: 152156Hom.: 1573 Cov.: 33 AF XY: 0.0755 AC XY: 5613AN XY: 74338
GnomAD3 exomes AF: 0.0206 AC: 5179AN: 251182Hom.: 611 AF XY: 0.0149 AC XY: 2021AN XY: 135744
GnomAD4 exome AF: 0.00849 AC: 12408AN: 1461642Hom.: 1420 Cov.: 32 AF XY: 0.00724 AC XY: 5263AN XY: 727130
GnomAD4 genome AF: 0.0785 AC: 11954AN: 152274Hom.: 1581 Cov.: 33 AF XY: 0.0758 AC XY: 5644AN XY: 74466
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
not specified Benign:1
*9G>A in exon 14 of CSF2RA: This variant is not expected to have clinical signif icance because it has been identified in 27.2% (1198/4406) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs141486727). -
Surfactant metabolism dysfunction, pulmonary, 4 Benign:1
- -
CSF2RA-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at